App store creator Cydia sued Apple Inc. for unspecified damages in the Oakland, California federal court for illegally monopolizing software distribution on its operating system.
Cydia, which was created in 2008, alleged that Apple has illegally squashed all competition for its App Store, thereby depriving consumers the choice of where to obtain iOS apps and developers from choosing distributors.
Cydia is said to be on the verge of closing and possible bankruptcy.
Apple said that it will review the lawsuit while insisting that it does not monopolize the market.
The Cupertino, California-based Apple also said it discourages consumers from trying to unlock their iPhones to install unauthorized software for security reasons.
Cydia, also known as SaurikIT, was created by software engineer Jay Freeman.
Apple has a market value exceeding $2 trillion.


Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline 



